BCC
CPRX

Bridge City Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Bridge City Capital’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.85M Sell
155,689
-994
-0.6% -$23.7K 1.07% 30
2025
Q4 		$3.66M Sell
156,683
-25,613
-14% -$571K 1.07% 33
2025
Q3 		$3.59M Buy
182,296
+66,415
+57% +$1.37M 0.96% 41
2025
Q2 		$2.51M Sell
115,881
-1,493
-1% -$35.2K 0.71% 64
2025
Q1 		$2.85M Buy
+117,374
New +$2.64M 0.85% 52

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bridge City Capital's CPRX Position: Q1 2026 in Review

Bridge City Capital reduced its Catalyst Pharmaceutical (CPRX) stake by 0.63% in Q1 2026, selling an estimated $23.7K and leaving 155,689 shares worth $3.85M. The position accounts for 1.07% of the portfolio, ranked #30.

Bridge City Capital first reported a position in CPRX in Q1 2025 and has held it in 5 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Bridge City Capital held 155,689 shares of Catalyst Pharmaceutical worth $3.85M as of Q1 2026.
  • Bridge City Capital sold 994 Catalyst Pharmaceutical shares in Q1 2026, an estimated $23.7K.
  • Catalyst Pharmaceutical made up 1.07% of Bridge City Capital's portfolio in Q1 2026, its #30 holding.
  • Bridge City Capital first reported a position in Catalyst Pharmaceutical in Q1 2025 and has held it in 5 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Bridge City Capital's 13F filing for Q1 2026, filed 13 May 2026.